Optimal market access requires insightful payer, provider, and patient engagement strategies aligned with precise sales execution. Barriers must be clearly understood and overcome through risk mitigation capabilities.
We analyzed approximately 400 plans and conducted primary research to provide a comprehensive view of powerful influencers (KOLs, payers) associated with decision-making for optimal engagement strategy with shifting market dynamics. That’s how data can enable strategies when expanding into new markets.
Value is achieved with Comprehensive Services, including:
The intelligence you need to validate or inform your strategy across the product life cycle.자세히 알아보기
Assess your pricing and launch strategies globally. Answer the complex questions impacting your revenue.자세히 알아보기
Strategies to support global launches and address complexities across markets.자세히 알아보기
Breaking down the complexity of reimbursement and access. Engaging the Patient, Payer and Provider.자세히 알아보기
신속하게 정제되는 임상 중심 데이터 기반 운영을 지원하는 완전한 자원 배분.자세히 알아보기
In a PM360 Focus on Payer Strategies feature, Brian Davis addresses the question: Besides efforts to lower drug prices and increase transparency, what market access challenges/barriers will cause pharma companies the most stress this year?